MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal
MediPharm Labs Corp. (TSXV: LABS, OTCQX: MEDIF, FSE: MLZ), is pleased to announce a white label agreement dated June 18,...
CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar
CymaBay Therapeutics (NASDAQ:CBAY) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug...
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy
Abeona Therapeutics (NASDAQ:ABEO) has announced that the US Food and Drug Administration (FDA) has granted the company fast track designation...
MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange
MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) is pleased to announce that the Company has applied to list...
MediPharm Labs Announces Closing of $75 Million Bought Deal Financing
MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation,...
PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from...
Entasis Therapeutics Announces Initial ETX0282 Phase 1 Results
Entasis Therapeutics Holdings (NASDAQ:ETTX) has announced initial preliminary results from its first-in-human Phase 1 clinical trial of its oral beta-lactamase...